THE EPIDEMIOLOGY AND INFECTION ROUTE OF ASYMPTOMATIC HCV CARRIERS DETECTED THROUGH BLOOD DONATIONS

被引:19
作者
SHIMOYAMA, R
SEKIGUCHI, S
SUGA, M
SAKAMOTO, S
YACHI, A
机构
[1] Medical Section, Hokkaido Red Cross Blood Center, Sapporo, 063, Yamanote 2-2, Nishi-ku
[2] First Department of Internal Medicine, Sapporo Medical College, Sapporo
来源
GASTROENTEROLOGIA JAPONICA | 1993年 / 28卷
关键词
D O I
10.1007/BF02989195
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The Japan Red Cross started screening donated blood for anti-HCV in Nov. 1989. Approximately 0.9% of donors were found to be positive by the 1st generation antibody test. The authors started a carrier clinic for the medical care of apparently healthy HCV carriers. Donors whose antibodies were strongly positive both by 1st EIA and 2nd PHA were informed, and were confirmed by RIBA 2 and RT-PCR. A total of 262 carriers (150 males and 112 females) with mean age of 46.8±11.2 yrs have visited the clinic. Of these carriers 149 were diagnosed to be asymptomatic clinically, biochemically and echographically. Eighty-seven carriers had received blood transfusions 22.7±10.9 yrs previously, while 106 had had acupuncture. Sixty had a family history of liver disease. Fifty-four had a history of heavy alcohol intake. Tattoos and/or iv drug abuse were found in 11, and nosocomial needle accidents in 4. HBV antibodies were found in 145 cases (55%). In conclusion, approximately 60% of HCV carriers found at the time of blood donation were apparently asymptomatic, suggesting the need of longer follow-up. Main routes of infection were estimated to be blood transfusion (33%), other parenteral exposure routes (6%), household (10% or less), and acupuncture (20% or less), considering duplication and priority. © 1993 The Japanese Society of Gastroenterology.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 12 条
[1]  
Kuo G., Choo Q.L., Alter H.J., Et al., An assay for circulating anti-bodies to a major etiologic virus of human non-A non-B hepatitis, Science, 244, pp. 362-364, (1989)
[2]  
Effect of screening for hepatitis C virus antibody and hepatitis B core virus antibody on incidence of post-transfusion hepatitis, Lancet, 338, pp. 1040-1041, (1991)
[3]  
Watanabe J., Minegishi K., Mitsumori T., Et al., Prevalence of anti-HCV antibody in blood donors in Tokyo area, Vox Sang, 59, pp. 86-88, (1990)
[4]  
van del Poel C.L., Cuypers H.T.M., Reesink H.W., Et al., Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay, Lancet, 337, pp. 317-319, (1991)
[5]  
Okamoto H., Okada S., Sugiyama Y., Et al., Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from 5′-noncoding region, Jpn J Exp Med, 60, pp. 215-222, (1990)
[6]  
Richards C., Holland P., Kuramoto K., Et al., Prevalence of antibody to hepatitis C virus in a blood donor population, Transfusion, 31, pp. 109-113, (1991)
[7]  
Kuhnl P., Seidl S., Trangel W., Et al., Antibody to hepatitis C virus in German blood donors, Lancet, 2, (1989)
[8]  
Sirchia G., Almini D., Bellobuono A., Et al., Prevalence of hepatitis C virus antibodies in Italian donors, Vox Sang, 59, pp. 26-29, (1990)
[9]  
Kiyosawa K., Sodeyama T., Tanaka E., Et al., Interrelationship of blood transfusion, non-A non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus, Hepatology, 12, pp. 671-675, (1990)
[10]  
Inoue Y., Miyamura T., Unayama T., Et al., Maternal transfer of HCV, Nature, 353, (1991)